http://www.rootsanalysis.comPresently, there are two approved drug and over 150 product candidates,

Table of Contents

1. PREFACE

2. EXECUTIVE SUMMARY

3. INTRODUCTION

4. COMPETITIVE LANDSCAPE

5. COMPANY COMPETITIVENESS ANALYSIS

6. LATE STAGE RNAi THERAPEUTICS

7. TECHNOLOGY PLATFORMS AND DELIVERY SYSTEMS

8. KEY THERAPEUTIC INDICATIONS

9. CLINICAL TRIAL ANALYSIS

10. PATENT ANALYSIS

11. RECENT PARTNERSHIPS

12. FUNDING AND INVESTMENT ANALYSIS

13. PROMOTIONAL ANALYSIS

14. MARKET SIZING AND OPPORTUNITY ANALYSIS

15. RNAi IN DIAGNOSTICS

16. SERVICE PROVIDERS FOR RNAi THERAPEUTICS

17. SWOT ANALYSIS

18. CONCLUSION

19. INTERVIEW TRANSCRIPT(S)

20. APPENDIX 1: TABULATED DATA

21. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/rnai-therapeutics-market-2nd-edition-2019-2030/278.html

Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
gaurav.chaudhary@rootsanalysis.com

Leave a Reply

Your email address will not be published. Required fields are marked *